{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:40:34Z","timestamp":1783330834887,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Berta Ottenstein Programme, Faculty of Medicine, University of Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0944-x","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T08:14:32Z","timestamp":1541664872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mapping health care of rare diseases: the example of epidermolysis bullosa in Germany"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3378-4476","authenticated-orcid":false,"given":"Antonia","family":"Reimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Bruckner-Tuderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"key":"944_CR1","volume-title":"Communication from the commission to the European parliament, the council, the European economic and social committee and the committee of the regions on Rare Diseases: Europe\u2019s challenges {SEC (2008)2713} {SEC (2008)2712}","author":"Commission on the European communities","year":"2008","unstructured":"Commission on the European communities. Communication from the commission to the European parliament, the council, the European economic and social committee and the committee of the regions on Rare Diseases: Europe\u2019s challenges {SEC (2008)2713} {SEC (2008)2712}. 2008. \n                    http:\/\/ec.europa.eu\/health\/ph_threats\/non_com\/docs\/rare_com_en.pdf\n                    \n                  ."},{"key":"944_CR2","volume-title":"Implementation report on the commission communication on rare diseases: Europe\u2019s challenges [COM (2008) 679 final] and council recommendation of 8 June 2009 on an action in the field of rare diseases (2009\/C 151\/02)","author":"European Commission","year":"2014","unstructured":"European Commission. Implementation report on the commission communication on rare diseases: Europe\u2019s challenges [COM (2008) 679 final] and council recommendation of 8 June 2009 on an action in the field of rare diseases (2009\/C 151\/02). 2014. \n                    https:\/\/ec.europa.eu\/health\/sites\/health\/files\/rare_diseases\/docs\/2014_rarediseases_implementationreport_en.pdf\n                    \n                  ."},{"key":"944_CR3","first-page":"7","volume":"C 151","author":"European Union","year":"2009","unstructured":"European Union. Council recommendation of 8 June 2009 on an action in the field of rare diseases (2009\/C 151\/02). Off J Eur Union. 2009;C 151:7\u201310.","journal-title":"Off J Eur Union"},{"key":"944_CR4","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(08)60872-7","volume":"371","author":"A Schieppati","year":"2008","unstructured":"Schieppati A, Henter J-I, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet. 2008;371:2039\u201341.","journal-title":"Lancet"},{"key":"944_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-016-0409-z","volume":"11","author":"C Molster","year":"2016","unstructured":"Molster C, Urwin D, Di Pietro L, Fookes M, Petrie D, van der Laan S, et al. Survey of healthcare experiences of Australian adults living with rare diseases. Orphanet J Rare Dis. 2016;11:30.","journal-title":"Orphanet J Rare Dis"},{"key":"944_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13023-017-0730-1","volume":"12","author":"KR Bogart","year":"2017","unstructured":"Bogart KR, Irvin VL. Health-related quality of life among adults with diverse rare disorders. Orphanet J Rare Dis. 2017;12:177.","journal-title":"Orphanet J Rare Dis."},{"key":"944_CR7","volume-title":"Nationaler Aktionsplan f\u00fcr Menschen mit Seltenen Erkrankungen","author":"Gesch\u00e4ftsstelle des Nationalen Aktionsb\u00fcndnisses f\u00fcr Menschen mit Seltenen Erkrankungen","year":"2013","unstructured":"Gesch\u00e4ftsstelle des Nationalen Aktionsb\u00fcndnisses f\u00fcr Menschen mit Seltenen Erkrankungen. Nationaler Aktionsplan f\u00fcr Menschen mit Seltenen Erkrankungen. 2013. \n                    https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/3_Downloads\/N\/NAMSE\/Nationaler_Aktionsplan_fuer_Menschen_mit_Seltenen_Erkrankungen_-_Handlungsfelder__Empfehlungen_und_Massnahmenvorschlaege.pdf\n                    \n                  . Accessed 9 Jun 2018."},{"key":"944_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","volume":"70","author":"J-D Fine","year":"2014","unstructured":"Fine J-D, Bruckner-Tuderman L, Eady RAJ, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70:1103\u201326.","journal-title":"J Am Acad Dermatol"},{"key":"944_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1610-0387.2006.06181.x","volume":"5","author":"A Volz","year":"2007","unstructured":"Volz A, Has C, Schumann H, Bruckner-Tuderman L. Network epidermolysis bullosa: molecular pathomechanisms and novel therapeutic approaches. JDDG J Dtsch Dermatol Ges. 2007;5:274\u20139.","journal-title":"JDDG J Dtsch Dermatol Ges."},{"key":"944_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature24487","volume":"551","author":"T Hirsch","year":"2017","unstructured":"Hirsch T, Rothoeft T, Teig N, Bauer JW, Pellegrini G, De Rosa L, et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature. 2017;551:327\u201332.","journal-title":"Nature"},{"key":"944_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/pde.12258","volume":"31","author":"R-CS Ahmad","year":"2014","unstructured":"Ahmad R-CS, Bruckner AL. A survey of epidermolysis bullosa care in the United States and Canada. Pediatr Dermatol. 2014;31:169\u201375.","journal-title":"Pediatr Dermatol"},{"key":"944_CR12","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/S0140-6736(08)60875-2","volume":"371","author":"S Aym\u00e9","year":"2008","unstructured":"Aym\u00e9 S, Kole A, Groft S. Empowerment of patients: lessons from the rare diseases community. Lancet. 2008;371:2048\u201351.","journal-title":"Lancet"},{"key":"944_CR13","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.healthpol.2014.12.016","volume":"119","author":"A Angelis","year":"2015","unstructured":"Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy. 2015;119:964\u201379.","journal-title":"Health Policy"},{"key":"944_CR14","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2133.2009.09306.x","volume":"161","author":"S Tabolli","year":"2009","unstructured":"Tabolli S, Sampogna F, Di Pietro C, Paradisi A, Uras C, Zotti P, et al. Quality of life in patients with epidermolysis bullosa. Br J Dermatol. 2009;161:869\u201377.","journal-title":"Br J Dermatol"},{"key":"944_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2340\/00015555-0947","volume":"90","author":"S Tabolli","year":"2010","unstructured":"Tabolli S, Pagliarello C, Uras C, Di Pietro C, Zambruno G, Castiglia D, et al. Family burden in epidermolysis bullosa is high independent of disease type\/subtype. Acta Derm Venereol. 2010;90:607\u201311.","journal-title":"Acta Derm Venereol"},{"key":"944_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/bjd.14104","volume":"174","author":"JE Mellerio","year":"2016","unstructured":"Mellerio JE, Robertson SJ, Bernardis C, Diem A, Fine JD, George R, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. Br J Dermatol. 2016;174:56\u201367.","journal-title":"Br J Dermatol"},{"issue":"F1000 Faculty R","key":"944_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.12688\/f1000research.14974.1","volume":"7","author":"D Kiritsi","year":"2018","unstructured":"Kiritsi D, Nystr\u00f6m A. Recent advances in understanding and managing epidermolysis bullosa [version 1; referees: 2 approved]. F1000Research. 2018;7(F1000 Faculty Rev):1097.","journal-title":"F1000Research"},{"key":"944_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jid.2015.10.050","volume":"136","author":"J Uitto","year":"2016","unstructured":"Uitto J, Bruckner-Tuderman L, Christiano AM, McGrath JA, Has C, South AP, et al. Progress toward treatment and cure of epidermolysis bullosa: summary of the DEBRA International research symposium EB2015. J Invest Dermatol. 2016;136:352\u20138.","journal-title":"J Invest Dermatol"},{"key":"944_CR19","unstructured":"Denyer J, Pillay E, Clapham J. International Consensus Best Practice Guidelines for Skin and Wound Care in Epidermolysis Bullosa: Wounds Int; 2017. \n                    http:\/\/www.debra-international.org\/clinical-guidelines\/complete-eb-guidelines\/wound-care.html\n                    \n                  . Accessed 30 Jun 2017"},{"key":"944_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-263X.2012.01247.x","volume":"22","author":"SM Kr\u00e4mer","year":"2012","unstructured":"Kr\u00e4mer SM, Serrano MC, Zillmann G, G\u00e1lvez P, Araya, Yanine N, et al. Oral health Care for Patients with epidermolysis bullosa - best clinical practice guidelines. Int J Paediatr Dent. 2012;22:1\u201335.","journal-title":"Int J Paediatr Dent"},{"key":"944_CR21","first-page":"271","volume":"28","author":"AE Martinez","year":"2010","unstructured":"Martinez AE. Tests to monitor in patients with severe types of epidermolysis bullosa. Epidermolysis Bullosa Part II \u2013 Diagn Manag. 2010;28:271.","journal-title":"Epidermolysis Bullosa Part II \u2013 Diagn Manag"},{"key":"944_CR22","first-page":"1","volume":"5203","author":"C Chiaverini","year":"2016","unstructured":"Chiaverini C, Bourrat E, Mazereeuw-Hautier J, Hadj-Rabia S, Bodemer C, Lacour J-P. \u00c9pidermolyses bulleuses h\u00e9r\u00e9ditaires : protocole national de diagnostic et de soins (PNDS). Ann Dermatol V\u00e9n\u00e9r\u00e9ologie. 2016;5203:1.","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"944_CR23","first-page":"1053","volume":"15","author":"V Oji","year":"2017","unstructured":"Oji V, Preil M, Kleinow B, Wehr G, Fischer J, Hennies HC, et al. S1 guidelines for the diagnosis and treatment of ichthyoses \u2013 update. JDDG J Dtsch Dermatol Ges. 2017;15:1053\u201365.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"944_CR24","doi-asserted-by":"publisher","unstructured":"Mazereeuw-Hautier J., Hernandez-Martin A., O\u2019Toole E.A., Bygum A., Amaro C., Aldwin M., et al. Management of congenital ichthyoses: European guidelines of care: Part Two. Br J Dermatol. 2018;0 ja. doi:\n                    https:\/\/doi.org\/10.1111\/bjd.16882\n                    \n                  .","DOI":"10.1111\/bjd.16882"},{"key":"944_CR25","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2016","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016. \n                    https:\/\/www.R-project.org"},{"key":"944_CR26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.32614\/RJ-2013-014","volume":"5","author":"D Kahle","year":"2013","unstructured":"Kahle D, Wickham H. ggmap: Spatial Visualization with ggplot2. R J. 2013;5:144\u201361.","journal-title":"R J"},{"key":"944_CR27","volume-title":"likert: Analysis and Visualization Likert Items","author":"J Bryer","year":"2016","unstructured":"Bryer J, Speerschneider K. likert: Analysis and Visualization Likert Items. 2016. \n                    https:\/\/CRAN.R-project.org\/package=likert\n                    \n                  ."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0944-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T19:11:08Z","timestamp":1573153868000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0944-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["944"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0944-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]},"assertion":[{"value":"14 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the University of Freiburg (vote Nr. 461\/17).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"197"}}